Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for
patients with chronic low back pain, when administered over a 6-week period.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.